100% Same
Salt CompositionEffectivenessStrength
with Substitute Medicine
Salt Composition in bothMetformin 500mg + Voglibose 0.3mg
You Searched
Our Recommendation
Vogliboz M 500/0.3mg SR Tablet 10s
4,077+ trust this
WHO GMP Certified
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
WHO GMP
Certified
15 Days Easy
Returns
Long Expiry
(>8 Months)
Delivery by
Used In
Treatment of Type 2 diabetes mellitus
Customers also bought
More About Voglaz M 0.3 Tablet SR 10s
Side Effects
Side effects of Voglaz-M Tablet SRThe majority of side effects typically do not necessitate medical intervention. and disappear as your body adjusts to the medicine. Doctor consultation is advised if they persist or if you�re worried about them Common side effects of Voglaz-MFlatulence Diarrhea Vomiting Abdominal pain Bloating Constipation Decreased appetite
How to use
How to use Voglaz-M Tablet SRFollow your doctor's guidance regarding the dose and duration of this medication. Ingest it without breaking or crushing. Do not chew, crush or break it. Voglaz M 0.3 Tablet SR is to be taken with food.
How it works
How Voglaz-M Tablet SR works Voglaz M 0.3 Tablet SR is a combination of two antidiabetic medicines:.
Unsafe: Avoid consuming alcohol with Voglaz M 0.3 Tablet SR as it is deemed unsafe.
Voglaz M 0.3 Tablet SR is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
Voglaz M 0.3 Tablet SR is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Voglaz M 0.3 Tablet SR should be used with caution in patients with kidney disease. Dose adjustment of Voglaz M 0.3 Tablet SR may be needed. Doctor consultation is advised.Use of Voglaz M 0.3 Tablet SR is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Voglaz M 0.3 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Voglaz M 0.3 Tablet SR may be needed. Doctor consultation is advised.Voglaz M 0.3 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
Manufacturer Address
#31, Sardar Pratap Singh Industrial Estate, No.2, L B S Marg, Bhandup (W), MUMBAI-400 078.
References
CiplaMed. Voglibose + Metformin hydrochloride (08 Apr. 2019)
Metformin hydrochloride. Princeton, New Jersey: Bristol-Myers Squibb Company (08 Apr. 2019)
Metformin hydrochloride oral solution. Gloversville, New York: Ranbaxy Pharmaceuticals Inc.; 2003 (08 Apr. 2019)
Dabhi AS, Bhatt NR, Shah MJ. Voglibose: An Alpha Glucosidase Inhibitor. J Clin Diagn Res. 2013;7(12):3023-7 (08 Apr. 2019)
Metformin hydrochloride and Voglibose (Tablets) (21 Oct. 2021)
Voglibose and Metformin Hydrochloride Tablets (28th Sept. 2023)
Disclaimer
PlatinumRx is dedicated to delivering dependable and trustworthy information to empower our customers. However, the information presented here is solely for general informational purposes and should not be utilized for diagnosing, preventing, or treating health issues. It is not intended to establish a doctor-patient relationship or serve as a substitute for professional medical advice.
Top Selling Medicines
Top Selling Devices
Flat Rs 100 on first app order | Use Code: APP100 |
Flat Rs 100 on first app order
USE CODE: APP100
Download Now
